SAN DIEGO — It was Novo Nordisk’s Ozempic and Wegovy that set off a new era in obesity medicine, delivering unprecedented levels of weight loss and working its way into popular culture, inescapable ads, and […]
SAN DIEGO — Ozempic and Wegovy became weight loss sensations by targeting a single hormone, leading people to lose as much as 15% of their weight. But that wasn’t enough — soon there was Mounjaro, […]
SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks […]
SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity […]
CARLSBAD, Calif. — Biotech companies developing cutting-edge cell and gene therapies often are tripped up by how much regulations around these drugs vary from country to country. On Wednesday, regulators from the United States, the […]
DNA sequencing giant Illumina announced Thursday that it would enter the field of drug discovery, a major shift for a company that, since its founding in 1998, has thrived instead by selling picks and shovels […]
If it wasn’t for a well-placed ad in the paper, Rob Perez might not have found his way to the life sciences industry. As he’ll tell you, he wasn’t on the traditional path to becoming […]
Guest Author: Sudip Parikh, Senior Vice President & Managing Director, Americas at DIA Global* I had a great experience as a Scripps Research graduate student in La Jolla. After graduating, I moved to the east […]
The biggest question in entrepreneurship is how does one take an idea and make it reality, make it something that?s tangible and positively affects an individual and society as a whole. This was the theme […]
Here at SDBN we?ve been updating our directory of 400+ San Diego biotech companies.? We were surprised to find close to 40 companies removed from the local scene ? due to acquisition or shut down.? […]
Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been […]
The Pathway Genomics business model is based on bridging a gap in personalized medicine.? As Ed MacBean, their VP of Product Development, explained at SDBN?s August 16th event, in a nutshell they connect clients through […]
Thanks to everyone who took our 2011 poll, the results are IN! See the slideshare presentation below which summarizes the results. Check out the word cloud based on the essay answers, with largest words representing […]
2011 is a new year for San Diego Biotech and we’re hoping that the good news will outweigh the bad. Let’s start off featuring a great company with a long history of success in the […]
Wednesday I attended a regenerative medicine-focused breakfast at the BIO convention and learned about San Diego company Advanced BioHealing (ABH), who took a ‘fallen’ asset, Dermagraft, and not only turned it into an $85M/year product, […]
On the San Diego Biotechnology Network LinkedIn group, we asked you what you wanted to hear about from the BIO Convention in Chicago, and you requested to hear about Biomarkers. Tuesday I attended a breakout […]
Drug development is an area that, according to our 2010 poll, you are interested in, and in previous meetings we’ve discussed that San Diego biotech could grow if we would better complement our drug discovery […]
Copyright © 2023 Biotech Networks, LLC
